skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: My biotech holdings include Celegene at 3% and alexion at 1.5%. I am looking to obtain a basket of these stocks, the best in your opinion, as opposed to getting the sector etf.
My question are as follows:
1. Do you feel now is an opportune time to be adding to biotech, or has the sector run up too far?
2. If the time is right, what would be your top complementary picks to my current positions ( mid cap to large cap) and how many should I hold? Please advise what an adequate overall portfolio position would be for the sector, for an investor with a palate for moderate risk and a long way term view.

Thank you for your counsel,
Karim .
Read Answer Asked by Karim on October 03, 2017
Q: 3:05 PM 9/27/2017

I have been looking at Extendicare as a source of slow growth and a good dividend, but I have a number of questions about the company that you may be able to answer.

1. What happened in May 2013 when the company cut the monthly dividend from 7 cents to 4 cents? In the same year Revenue dropped from $2,037 million in 2012 to $784 million in 2013 and Operating Income was cut in half.

2. Morningstar shows Equity of $135 million and Debt of $533 million. Can you explain these figures as they relate to Market Cap of $823 million?

3. What is the actual current $ debt, and Debt/Cashflow, and is it unacceptably high?

4. What do you think of management and do you forsee any problems ahead for the company other than inflation and minimum wage increases.

5. Do you have any concerns about the company's ability to continue paying the 4 cent a month 5.2% dividend?

6. INK insider shows that there has been good net insider buying in the last year at EXE with the CEO almost doubling his holding to 240,000 shares with rights to an additionsl 197,000+ shares. In contrast I note that Directors at Sienna have sold nearly 200,000 shares of SIA in the last year. Does this hint at trouble at Sienna and better days ahead for Extendicare?

7. Would you consider EXE's dividend any more or less reliable that those of SIA or CSH.UN? I currently have a 1% position in EXE.

8. Would adding new Money to my 1% position in EXE for the dividend, be a complement to my positions in SIA [4%] and in CSH.UN [3%]?

Thank you very much............ Paul K.

Read Answer Asked by Paul on September 28, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!